Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

2.

[High dosage stain protects heart and brain from recurrence].

[No authors listed]

MMW Fortschr Med. 2008 Nov 27;150(48):118-9. German. No abstract available.

PMID:
19125516
3.

Therapeutic dose assessment of patient switching from atorvastatin to simvastatin.

Hess G, Sanders KN, Hill J, Liu LZ.

Am J Manag Care. 2007 Jun;13 Suppl 3:S80-5. Erratum in: Am J Manag Care. 2007 Jul;13(7):432.

5.

Cost-effectiveness analysis of rosuvastatin versus atorvastatin, simvastatin, and pravastatin from a Canadian health system perspective.

Costa-Scharplatz M, Ramanathan K, Frial T, Beamer B, Gandhi S.

Clin Ther. 2008 Jul;30(7):1345-57.

PMID:
18691996
6.

Cost-effectiveness of high-dose atorvastatin compared with regular dose simvastatin.

Lindgren P, Graff J, Olsson AG, Pedersen TJ, J├Ânsson B; IDEAL Trial Investigators.

Eur Heart J. 2007 Jun;28(12):1448-53. Epub 2007 Mar 19.

PMID:
17371782
7.
8.

[Ezetimib plus statin combination. A strong duo].

[No authors listed]

MMW Fortschr Med. 2002 Nov 28;144(48):53. German. No abstract available.

PMID:
12532547
9.

Comparison of atorvastatin 80 mg/day versus simvastatin 20 to 40 mg/day on frequency of cardiovascular events late (five years) after acute myocardial infarction (from the Incremental Decrease in End Points through Aggressive Lipid Lowering [IDEAL] trial).

Pedersen TR, Cater NB, Faergeman O, Kastelein JJ, Olsson AG, Tikkanen MJ, Holme I, Larsen ML, Lindahl C, Szarek M.

Am J Cardiol. 2010 Aug 1;106(3):354-9. doi: 10.1016/j.amjcard.2010.03.033.

PMID:
20643245
10.

Switching from atorvastatin to simvastatin in patients at high cardiovascular risk: effects on low-density lipoprotein cholesterol.

Aronow HD, Hess G, Hill J, Kuznik A, Liu LZ.

Am J Ther. 2010 Mar-Apr;17(2):167-75. doi: 10.1097/MJT.0b013e3181b442b9.

PMID:
19770794
12.

Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.

Jones PH, Hunninghake DB, Ferdinand KC, Stein EA, Gold A, Caplan RJ, Blasetto JW; Statin Therapies for Elevated Lipid Levels Compared Across Doses to Rosuvastatin Study Group.

Clin Ther. 2004 Sep;26(9):1388-99. Erratum in: Clin Ther. 2005 Jan;27(1):142.

PMID:
15531001
13.

Statin's cost-effectiveness: a Canadian analysis of commonly prescribed generic and brand name statins.

Tran YB, Frial T, Miller PS.

Can J Clin Pharmacol. 2007 Summer;14(2):e205-14. Epub 2007 Jun 5.

PMID:
17556788
14.

[Sequelae of the CARDS Study. LDL of 110 mg/dl still too high?].

Klose G.

MMW Fortschr Med. 2004 Jun 24;146(26):14. German. No abstract available.

PMID:
15529683
15.

Atorvastatin (Lipitor).

Tucker G.

Conn Med. 1998 May;62(5):283-5. No abstract available.

PMID:
9639958
16.

Reduction in cardiovascular events with atorvastatin in type 2 diabetes.

Clearfield M.

Curr Atheroscler Rep. 2006 Jan;8(1):9-10. No abstract available.

PMID:
16455007
17.

Beneficial effects of high atorvastatin dose reloading prior to percutaneous coronary intervention.

Katsiki N, Athyros VG, Karagiannis A.

Curr Med Res Opin. 2014 Jan;30(1):55. doi: 10.1185/03007995.2013.842546. Epub 2013 Oct 25. No abstract available.

PMID:
24024869
18.
19.

Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

Jones P, Kafonek S, Laurora I, Hunninghake D.

Am J Cardiol. 1998 Mar 1;81(5):582-7. Erratum in: Am J Cardiol 1998 Jul 1;82(1):128.

PMID:
9514454
20.

Safety of high-dose atorvastatin therapy.

Waters DD.

Am J Cardiol. 2005 Sep 5;96(5A):69F-75F. Review.

PMID:
16126026

Supplemental Content

Support Center